The experimental weight-loss drug retatrutide, which has not yet been approved for the European market, is on the rise in the Netherlands. Hundreds of Dutch people are estimated to use the drug, bought mostly via TikTok, the Telegraaf reported after speaking with users and sellers. Retatrutide is being developed for patients with obesity, and scientific research into its effects is still ongoing. The European Medicines Agency hasn’t even received an application for approval yet, since the drug […]

Read more

Moorfields Eye Hospital has published a new page on its website providing insight on the eye health risks and benefits of GLP-1 agonists. The use of GLP-1 medications – such as Wegovy, Ozempic and Mounjaro – for weight management has increased in recent years. Following the rising popularity of these drugs, research explored potential associations between GLP-1 agonists and the risk of certain eye conditions – such as Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) and age-related macular […]

Read more

Australians will soon be able to swap weight-loss injections for a pill, with a new form of popular medicine Wegovy approved by the Therapeutic Goods Administration. A once-daily pill will be available to Australians before Christmas, according to 7NEWS, with more than 10,000 residents already signed up to the waiting list. Wegovy manufacturer Novo Norsdisk said the company was “working to bring the new treatment option”, with other GLP-1 medications such as Wegovy, Ozempic and Mounjaro only […]

Read more

It has been more than four years since this publication called out the fact that the suddenly and sus­piciously skinny people in your life had something in common: a prescription for a then-under-the-radar drug called Ozempic. Since then, GLP-1s have become ubiquitous and quotidian, shedding the secrecy that initially surrounded them. Until now—because once again there’s a new drug on the block, and it is hush-hush. For good reason: It’s not yet FDA approved, which means the […]

Read more

Wegovy is set to become available in pill form across Australia, after the Therapeutic Goods Administration (TGA) granted approval for eligible patients. In a statement, manufacturer Novo Nordisk said they were “working to bring the new treatment option” to eligible Australians later in the year, while promising to share future updates. Novo submitted an application to sell GLP-1 pills with the TGA earlier this year, following approval that was granted in the US and UK. Currently, Wegovy […]

Read more

The Therapeutic Goods Administration has approved Australia’s first oral weight-loss medication. The TGA greenlit Novo Nordisk’s Wegovy tablets, which contain semaglutide, the same active ingredient used in the popular jabs. The approval covers four strengths: 1.5mg, 4mg, 9mg and 25mg. The tablets were approved for weight management and to help reduce the risk of major cardiovascular events in at-risk patients. “The indications are consistent with those approved for the injectable formulation of Wegovy,” a Department of Health […]

Read more

The hardest part of losing weight isn’t knowing what to eat — it’s the time and effort it takes to meal-plan and grocery-shop that often get in the way. Sticking to, or even identifying, a single portion is another potential roadblock. That’s where the best weight loss meal delivery services can be a game-changer. From veggie-forward meal kits to preportioned, ready-to-eat options, these services can save hours of planning, shopping and cooking, helping remove one of the […]

Read more

The number of online shops illegally selling weight-loss products is increasing at an alarming rate. An RTL Nieuws investigation discovered 203 such illegal pharmacies, over half of which are less than six months old. According to BNR, these sites are mainly supplied from China – one of the world’s largest producers of peptides. Dutch Customs and the Health and Youth Care Inspectorate are struggling to address the increasing import of counterfeit medication from China. According to RTL, […]

Read more

Since GLP-1 weight-loss medications exploded in popularity a few years ago, Chitra Ganta, MD, a geriatrician at the Cleveland Clinic, has seen a flood of interest from her patients. She had already witnessed the positive effect of these medications on diabetes management in the years prior to their approval for weight loss and was excited to be able to offer them to her patients who have struggled for years with obesity. “Once the GLP-1s came out, they […]

Read more